CI Stock Recent News
CI LATEST HEADLINES
Cigna's stock drop after Q2 2025 is overdone; shares now trade at a 15% discount to their 5-year average, creating a compelling entry point. Despite mixed Q2 results and lower profit growth forecasts, my DCF model supports a fair value of $315 per share, implying 8.5% upside. Aggressive share buybacks and steady dividend growth enhance shareholder returns, while Cigna maintains strong cash flows and manageable debt.
Lisa Gill, JP Morgan healthcare analyst, on “Worldwide Exchange,” says healthcare is at an inflection point, with UnitedHealth poised for long-term gains as big investors bet on a turnaround.
Cigna offers a lower-risk profile after selling its Medicare business, avoiding Medicare headwinds impacting peers like UnitedHealth Group. However, the stock price has fallen alongside UNH. Recent earnings were strong, guidance was affirmed, and valuation is attractive, with Wall Street seeing up to 35% upside potential. Risks remain from medical inflation and PBM regulatory scrutiny, but Cigna's business mix provides more pricing power and operational flexibility than UNH.
Deutsche Bank analyst George Hill raised the firm's price target on Cigna to $415 from $372 and keeps a Buy rating on the shares. 30 Oct
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cigna (CI) have what it takes?
Cigna beat Wall Street estimates for second-quarter profit on Thursday, helped by strength in its pharmacy benefit management business.
CI's Q2 earnings benefit from strong Evernorth Health Services unit, offsetting customer losses and rising costs. It continues to expect 2025 adjusted EPS at a minimum of $29.60.
The Cigna Group (NYSE:CI ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Ann M. Dennison - Executive VP & CFO Brian C.
The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.